APA (7th ed.) Citation

Powles, T., Eder, J. P., Petrylak, D. P., Fine, G. D., Teng, S., Shen, X., . . . Vogelzang, N. J. (2014). MPDL3280A (anti-PD-L1) treatment leads to clinical activity in metastatic bladder cancer. Nature, 515(7528), 558. https://doi.org/10.1038/nature13904

Chicago Style (17th ed.) Citation

Powles, Thomas, et al. "MPDL3280A (anti-PD-L1) Treatment Leads to Clinical Activity in Metastatic Bladder Cancer." Nature 515, no. 7528 (2014): 558. https://doi.org/10.1038/nature13904.

MLA (9th ed.) Citation

Powles, Thomas, et al. "MPDL3280A (anti-PD-L1) Treatment Leads to Clinical Activity in Metastatic Bladder Cancer." Nature, vol. 515, no. 7528, 2014, p. 558, https://doi.org/10.1038/nature13904.